US equities
|
MU
$939.51
▼-5.01%
META
$761.54
▲+2.50%
NVDA
$226.97
▲+0.29%
SNDK
$1,453.55
▼-2.27%
AAPL
$343.80
▲+0.83%
SPCX
$157.26
▼-3.77%
MSFT
$545.74
▲+0.85%
AMD
$601.16
▲+1.16%
MU
$939.51
▼-5.01%
META
$761.54
▲+2.50%
NVDA
$226.97
▲+0.29%
SNDK
$1,453.55
▼-2.27%
AAPL
$343.80
▲+0.83%
SPCX
$157.26
▼-3.77%
MSFT
$545.74
▲+0.85%
AMD
$601.16
▲+1.16%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Articles published by Rubius Therapeutics
Rubius Therapeutics Announces Process to Explore Strategic Alternatives and Leadership Changes
November 02, 2022
From
Rubius Therapeutics
Via
GlobeNewswire
Tickers
RUBY